Epiretinal membrane (ERM) is a common condition that affects the eyes of millions of people worldwide. It is a thin, transparent layer of tissue that forms on the surface of the retina, the light-sensitive layer of tissue at the back of the eye. ERM can cause a variety of vision problems, including blurred vision, reduced contrast sensitivity, and difficulty with night vision. In some cases, ERM can lead to permanent vision loss. Despite its prevalence, the exact cause of ERM is still not fully understood. In this article, we will explore the current understanding of ERM and discuss the latest advances in diagnosis and treatment.
Epiretinal membrane is a thin, transparent layer of tissue that forms on the surface of the retina. It is composed of collagen and other proteins, and is usually caused by the contraction of scar tissue that forms after a retinal tear or detachment. In some cases, ERM can be caused by an inflammatory process or a reaction to a surgical procedure. ERM can cause a variety of vision problems, including blurred vision, reduced contrast sensitivity, and difficulty with night vision. In some cases, ERM can lead to permanent vision loss.
ERM is typically diagnosed using a combination of physical examination, imaging tests, and other diagnostic techniques. During the physical examination, the doctor will look for signs of ERM, such as a retinal tear or detachment. Imaging tests, such as optical coherence tomography (OCT) and fluorescein angiography, can also be used to diagnose ERM. OCT is a non-invasive imaging technique that uses light to create detailed images of the retina. OCT can be used to detect the presence of ERM, as well as to evaluate the extent of the condition. Fluorescein angiography is a specialized imaging technique that uses a dye to highlight areas of the retina that are affected by ERM.
The treatment of ERM depends on the severity of the condition. In mild cases, treatment may not be necessary. However, in more severe cases, treatment may be necessary to prevent vision loss. The most common treatment for ERM is a surgical procedure called vitrectomy. During this procedure, the vitreous gel that fills the eye is removed and replaced with a gas or silicone oil bubble. This helps to reduce the tension on the retina and prevent further damage. In some cases, medications may be used to reduce inflammation and improve vision. Corticosteroids, such as prednisone, may be prescribed to reduce inflammation and improve vision.
Epiretinal membrane is a common condition that affects the eyes of millions of people worldwide. It is a thin, transparent layer of tissue that forms on the surface of the retina, the light-sensitive layer of tissue at the back of the eye. ERM can cause a variety of vision problems, including blurred vision, reduced contrast sensitivity, and difficulty with night vision. In some cases, ERM can lead to permanent vision loss. Diagnosis of ERM typically involves a combination of physical examination, imaging tests, and other diagnostic techniques. Treatment of ERM depends on the severity of the condition and may include surgery, medications, or a combination of both. With the latest advances in diagnosis and treatment, doctors are now better equipped to diagnose and treat ERM and help patients preserve their vision.
1.
Short-course radiation matches standard therapy for endometrial cancer
2.
AMA President-Elect Confronts a New Challenge: A Brain Tumor
3.
A study suggests that you should disregard the "pack-years" when determining your eligibility for lung cancer screening.
4.
In a randomized trial, the kinder, gentler regimen for classical Hodgkin wins out.
5.
Adjuvant therapy for hepatocellular carcinoma after curative treatment: Several unanswered questions
1.
Managing Acute Respiratory Failure in Hematological Malignancies
2.
Unmasking the Subtle Symptoms of Colon Cancer
3.
Unlocking the Key to Treating Lymphoma: New Innovations in Cancer Research
4.
The Latest Research on Acute Promyelocytic Leukemia: Advancements in Diagnosis and Therapy
5.
The Predictive Power of Targeted Radionuclide Therapy in Advanced Breast Cancer
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
2.
Navigating the Complexities of Ph Negative ALL - Part XIV
3.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Further Discussion on A New Perspective
4.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part V
5.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation